Purple Biotech Ltd (NASDAQ:PPBT – Free Report) – Stock analysts at HC Wainwright reduced their Q3 2024 EPS estimates for Purple Biotech in a research report issued on Tuesday, May 21st. HC Wainwright analyst E. Bodnar now forecasts that the company will post earnings per share of ($0.13) for the quarter, down from their previous […]